These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 151805)

  • 1. Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally.
    Hook EB
    N Engl J Med; 1978 Nov; 299(19):1036-8. PubMed ID: 151805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal abnormality rates at amniocentesis and in live-born infants.
    Hook EB; Cross PK; Schreinemachers DM
    JAMA; 1983 Apr; 249(15):2034-8. PubMed ID: 6220164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective birth in twin pregnancy with discordancy for Down's syndrome.
    Kerenyi TD; Chitkara U
    N Engl J Med; 1981 Jun; 304(25):1525-7. PubMed ID: 6453296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age.
    Kratzer PG; Golbus MS; Schonberg SA; Heilbron DC; Taylor RN
    Am J Med Genet; 1992 Nov; 44(5):657-63. PubMed ID: 1481829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age.
    Hook EB
    Am J Hum Genet; 1983 Jan; 35(1):110-6. PubMed ID: 6218752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between rates of trisomy 21 (Down syndrome) and other chromosomal abnormalities diagnosed in livebirths and in cells cultured after second-trimester amniocentesis--suggested explanations and implications for genetic counseling and program planning.
    Hook EB
    Birth Defects Orig Artic Ser; 1978; 14(6C):249-67. PubMed ID: 153158
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural selection, selection bias and the prevalence of Down's syndrome.
    Oakley GP
    N Engl J Med; 1978 Nov; 299(19):1068-9. PubMed ID: 151806
    [No Abstract]   [Full Text] [Related]  

  • 19. Rates of trisomy 18 in livebirths, stillbirths, and at amniocentesis.
    Hook EB; Woodbury DF; Albright SG
    Birth Defects Orig Artic Ser; 1979; 15(5C):81-93. PubMed ID: 160807
    [No Abstract]   [Full Text] [Related]  

  • 20. Trisomy 21 in one of twin fetuses.
    Heller RH; Palmer LS
    Pediatrics; 1978 Jul; 62(1):52-3. PubMed ID: 150585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.